Delivery Order SPE2DB24D2205-SPE2DB26FDSHB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,752.85 and an ultimate completion date of August 7, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.51 to AmerisourceBergen Drug Corp for 100 tablets of Quillichew ER 30 mg chew tablets. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chewable tablets (100-count) valued at $9,871.48. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under a firm fixed price structure with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,045.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $3,029.89 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quillichew ER 20 mg chew tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 17, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count) with a ceiling value of $2,970.74. This is a firm fixed price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100-count) on April 25, 2025. This competitive, non-set-aside contract reflects a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. The product will be performed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $4,699.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Quillichew ER 20 mg chewable tablets (100-count units). This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.06 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract employs firm fixed price terms and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Quillichew ER 30 mg chewing tablets (100-count units) with a ceiling value of $1,033.15. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The order is scheduled for ultimate completion by September 30, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSHBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a contract value of $8,334.51. This is a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts encompasses a wide range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a non-set-aside contractor operating under open competition, AmerisourceBergen demonstrates the capability to meet federal procurement requirements and serves customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 10/14/25 |